The European Commission has granted regulatory approval, concluding the acquisition of iconic Italian motorsports brand Dainese by asset management firms Arcmont and HPS Investment Partners, effectively placing ownership under major institutional investors.
Qatar has tripled its flagship venture capital fund to $3 billion, adding a strategic sweetener: subsidized access to AI computing power. The move aims to position Doha as a competitive hub for tech talent and deep-tech startups in the Gulf region.
Amid persistent inflation and shifting trade policies, building a robust financial safety net is more crucial than ever. Experts outline actionable steps to grow your savings, from debt management to smart account allocation.
While speculative stories often captivate investors, Autoneum Holding (VTX:AUTN) presents a case built on profitability and insider conviction. We examine whether its strong EPS growth and significant insider ownership justify a spot on your watchlist.
A discounted cash flow analysis suggests Westinghouse Air Brake Technologies (Wabtec) shares may be trading at a premium. We break down the valuation model, its assumptions, and the broader market forces at play for the rail equipment leader.
In a strategic move to diversify its portfolio and strengthen its European footprint, UK-based The Tofoo Co., backed by private equity, has acquired German seitan specialist Topas, owner of the Wheaty brand.
Digital asset investment products faced a second consecutive week of massive withdrawals, totaling $1.7 billion, pushing year-to-date flows into negative territory amid a hawkish Fed and market uncertainty.
Senior U.S. envoy Steve Witkoff is set to arrive in Jerusalem for meetings with Prime Minister Netanyahu and military leaders, as Washington seeks to navigate escalating regional tensions with Iran and advance efforts to end the Gaza conflict.
A convoy of Syrian government forces was observed moving toward the strategic northeastern city of Hasakah on Monday, implementing a ceasefire agreement that aims to reintegrate Kurdish-administered territories with Damascus.
The Rafah border crossing, Gaza's sole gateway to Egypt, has partially reopened for pedestrian traffic after a prolonged Israeli closure, offering a fragile hope for medical evacuations and family reunifications.
Former President Donald Trump has announced Kevin Warsh, a former Federal Reserve governor and economic advisor, as his pick to lead the central bank. The nomination comes as incumbent Chair Jerome Powell faces a federal investigation related to his congressional testimony.
Amgen has transferred full rights for the atopic dermatitis drug rocatinlimab back to Kyowa Kirin, clearing the path for the Japanese firm to pursue US approval by 2026. The move comes despite the drug meeting all trial endpoints, reflecting Amgen's portfolio reprioritization and a tempered market outlook for the OX40 inhibitor class.
A landmark tripartite agreement between financial heavyweight Schroders, battery leader CATL, and investment firm Lochpine Capital aims to deploy up to 10GWh of energy storage across Europe, marking a significant step in the continent's clean energy transition.
As mortgage rates fluctuate and ambitious policy ideas emerge, economists warn that financing tweaks cannot solve the core issue: a chronic shortage of homes.
Hong Kong apparel giant Crystal International is investing in a high-tech logistics center in China, aiming to slash fabric transfer times by 75% and power operations with solar energy as part of its broader smart manufacturing push.
Chinese biotech firm Arctic Vision moves to create an integrated ophthalmology powerhouse by acquiring MDCO Technology's device business, combining drug and device expertise to address unmet needs in eye care.
Analyst Joe Laetsch raises HF Sinclair's price target, highlighting favorable crude differentials and a recent $38 million acquisition aimed at expanding its lubricants business, as the refiner lands on a list of top low-risk dividend stocks.
Despite a partial recovery, Pfizer's stock remains significantly below its pandemic-era peak. As 2026 approaches, the pharmaceutical giant confronts a critical juncture defined by looming patent expirations, a high-stakes catch-up effort in the lucrative GLP-1 market, and a dividend under pressure.
A provocative analysis suggests the widespread adoption of GLP-1 drugs like Ozempic and Wegovy could trim airline fuel bills by reducing passenger weight, potentially passing savings to travelers. But industry experts debate whether the math adds up.
While a recent executive order aims to streamline AI rules, experts caution that customer experience teams face a complex transition—not a regulatory holiday—demanding stronger internal governance.
